Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the reason why the new Apple Watch Series 10 doesn’t have blood oxygen features in the US.

Masimo Corporation MASI, on Friday, announced a partnership with Google. The tie-up aims to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google smartwatches.

Google and Masimo partnership will offer “reference platforms” to Wear OS brands. A little over three years ago, Google and Samsung announced Wear OS 3.0 as a “merger” of

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health tracking.

Masimo has announced collaboration with Google and Qualcomm to build a smartwatch reference platform for OEMs to use. Read on to know more!

Masimo (MASI) partners with Google (GOOG) to develop a new reference platform for original equipment manufacturers

Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms, integrating Masimo's advanced medical sensors and Qualcomm's Snapdragon chipsets.

Global medical innovator Masimo has announced a partnership with Google to develop a new reference platform for original equipment manufacturers (OEMs)